In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Mind Medicine Inc (NASDAQ: MNMD) closed at $10.0 up 1.52% from its previous closing price of $9.85. In other words, the price has increased by $1.52 from its previous closing price. On the day, 1.29 million shares were traded. MNMD stock price reached its highest trading level at $10.2894 during the session, while it also had its lowest trading level at $9.78.
Ratios:
For a deeper understanding of Mind Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.98 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On January 28, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $23.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.Chardan Capital Markets initiated its Buy rating on December 20, 2024, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 25 ’25 when Sullivan Mark sold 11,491 shares for $6.80 per share. The transaction valued at 78,139 led to the insider holds 305,130 shares of the business.
Karlin Daniel sold 7,848 shares of MNMD for $53,366 on Jun 25 ’25. The Chief Medical Officer now owns 438,329 shares after completing the transaction at $6.80 per share. On Jun 25 ’25, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 26,491 shares for $6.80 each. As a result, the insider received 180,139 and left with 830,065 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 760879040 and an Enterprise Value of 619077440.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.97, which has changed by 0.5174507 over the last 52 weeks, in comparison to a change of 0.17279088 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $10.44, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 22.91%, while the 200-Day Moving Average is calculated to be 38.24%.
Shares Statistics:
For the past three months, MNMD has traded an average of 1.24M shares per day and 1215930 over the past ten days. A total of 75.80M shares are outstanding, with a floating share count of 72.87M. Insiders hold about 3.55% of the company’s shares, while institutions hold 54.14% stake in the company. Shares short for MNMD as of 1752537600 were 11224668 with a Short Ratio of 9.07, compared to 1749772800 on 11065859. Therefore, it implies a Short% of Shares Outstanding of 11224668 and a Short% of Float of 14.92.
Earnings Estimates
The market rating for Mind Medicine Inc (MNMD) is a result of the insights provided by 7.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.43 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$1.61 and -$1.95 for the fiscal current year, implying an average EPS of -$1.77. EPS for the following year is -$1.85, with 8.0 analysts recommending between -$1.0 and -$2.47.
